Miscellaneous dermatological conditions:
Indications for ESKATA:
Raised seborrheic keratoses.
For topical application by healthcare provider. Apply 4 times to targeted lesion(s) approx. 1min apart during a single session. May administer another treatment if lesions have not cleared after 3 weeks.
Not for oral, ophthalmic, or intravaginal use. Avoid open or infected seborrheic keratoses, lesions within orbital rim, eyes and mucous membranes.
Erythema, stinging, edema, scaling, crusting, pruritus, vesiculation, erosion, ulceration, hyper/hypopigmentation.
Generic Drug Availability:
Pen applicator (1.5mL, 2.2mL)—1, 3, 12